A class action lawsuit has been filed against Genius Group Limited and some of its officers for allegedly engaging in illegal spoofing practices that manipulated the stock price between April 2022 and May 2025. The complaint claims the defendants placed fake buy and sell orders to create false market activity, increasing transaction costs and misleading investors. Investors who bought Genius securities during this period are encouraged to join the lawsuit before the August 28, 2026 deadline to seek damages. The law firm Bronstein, Gewirtz & Grossman represents affected investors on a contingency fee basis, meaning no upfront cost for plaintiffs.
The FDA has approved Casgevy, a gene therapy using CRISPR technology, for children aged 2 and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). This therapy modifies patients' own stem cells to increase fetal hemo...
Guggenheim Investments declared distributions for multiple closed-end funds, including Advent Convertible Income Fund and Guggenheim Strategic Opportunities Fund, with payments scheduled for July 31, 2026. These distributions may include income, capi...
AI/R Avenue Code, a subsidiary of AI/R, has achieved Google's Gemini Enterprise competency, recognizing its expertise in deploying advanced AI solutions securely in enterprises. This certification highlights their strengths in security, workflow auto...
A Tesla electric Semi truck was involved in its first fatal accident on June 28, 2026, in Dayton, Nevada, where it collided with a small Volkswagen Beetle, killing both occupants. The Tesla driver was unharmed, and preliminary reports suggest the tru...
Aave, a leading decentralized lending protocol, saw its largest single-day increase in new Ethereum wallets since October 2021, adding 1,806 wallets on June 30. This surge coincided with a 9% rise in the AAVE token price, reaching about $86.94. The g...
